Volume 21, Issue 8 pp. 3598-3602
ORIGINAL ARTICLE

Do patients with psoriasis are at higher risk for atherogenity? A case–control study

Hakan Aksoy MD

Hakan Aksoy MD

Department of Cardiology, Memorial Ankara Hospital, Ankara, Turkey

Search for more papers by this author
Gulhan Aksoy Sarac MD

Corresponding Author

Gulhan Aksoy Sarac MD

Department of Dermatology, Faculty of Medicine, Ufuk University, Ankara, Turkey

Correspondence

Gulhan Aksoy Sarac, Department of Dermatology, Faculty of Medicine, Ufuk University, Ankara, Turkey.

Email: [email protected]

Search for more papers by this author
Didem Dinçer Rota MD

Didem Dinçer Rota MD

Department of Dermatology, Faculty of Medicine, Ufuk University, Ankara, Turkey

Search for more papers by this author
Onur Acar MD

Onur Acar MD

Ağrı Provincial Health Directorate, Public Health, Ağrı, Turkey

Search for more papers by this author
Tufan Nayır MD

Tufan Nayır MD

Republic of Turkey Ministry of Health, Ankara, Turkey

Search for more papers by this author
First published: 05 April 2022

Abstract

Background

Psoriasis is a chronic, inflammatory skin disease that is common in both adult and childhood. Patients with psoriasis are at significant risk for the development of many comorbid conditions, including cardiovascular diseases.

Objectives

We aimed to investigate the cardiovascular risk status and serum lipid parameters in patients with psoriasis and to determine the risk of cardiovascular disease by atherogenic indices obtained accordingly.

Methods

This retrospective case-control study was conducted with a total of 142 individuals, 72 patients with psoriasis vulgaris and 70 healthy volunteers over the age of 18 who were admitted to the dermatology outpatient clinic. Demographic information and laboratory values were retrieved from the hospital database. Afterward, atherogenic indexes such as Atherogenic index of plasma (AIP), Castelli Risk Index I and II (CRI-I and II), and Atherogenic coefficient (AC) were calculated.

Results

There was a significant difference in lipid profile between the psoriasis patients and the control group. In patients with psoriasis, triglyceride level (140.09 ± 71.20 mg/dl vs. 116.10 ± 63.95, p = 0.037) was higher, while HDL level (44.34 ± 11.77 mg/dl vs. 50.31 ± 11.62, p = 0.003) was lower. Regarding atherogenic indices; AIP (0.10 ± 0.24 vs. −0.04 ± 0.27, p = 0.001), CRI-I (4.63 ± 1.40 vs. 3.94 ± 1.02, p = 0.001), CRI-II (2.98 ± 1.01 vs. 2.61 ± 0.82, p = 0.019) and AC (3.63 ± 1.40 vs.. 2.94 ± 1.02, p = 0.001) were significantly higher in patients with psoriasis.

Conclusion

Our study shows that patients with psoriasis have higher pro-atherogenic lipid profile and atherogenic indexes at a high risk level. Patients with psoriasis have an increased risk of cardiovascular diseases.

CONFLICT OF INTEREST

No conflict of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.